Product
QLM3004
1 clinical trial
1 indication
Indication
MyopiaClinical trial
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Different Concentrations of QLM3004 in Delaying the Progression of Myopia in ChildrenStatus: Recruiting, Estimated PCD: 2026-06-01